{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:17:12Z","timestamp":1791274632527,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12350-019-01976-6","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T16:02:36Z","timestamp":1575907356000},"page":"2141-2148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["18F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis"],"prefix":"10.1016","volume":"28","author":[{"given":"Sho","family":"Furuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Naya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Koyanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Magota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Oyama-Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohsuke","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagara","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-019-01976-6_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.17996\/anc.17-00015","article-title":"Qualitative and quantitative assessments of cardiac sarcoidosis using 18F-FDG PET","volume":"3","author":"Manabe","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-019-01976-6_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13550-017-0315-y","article-title":"Semi-quantitative metabolic values on FDG PET\/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis","volume":"7","author":"Ishiyama","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-019-01976-6_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13550-018-0447-8","article-title":"Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?","volume":"8","author":"Furuya","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-019-01976-6_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of (18)F-FLT and (18)F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-019-01976-6_bib5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00259-011-1832-y","article-title":"(1)(8)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"38","author":"Ohira","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01976-6_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01976-6_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01976-6_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12350-016-0495-2","article-title":"(18)F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis","volume":"24","author":"Manabe","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01976-6_bib9","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00259-014-2810-y","article-title":"Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma","volume":"41","author":"Sato","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01976-6_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-019-01976-6_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.nucmedbio.2005.03.010","article-title":"Fully automated one-pot synthesis of [18F]fluoromisonidazole","volume":"32","author":"Tang","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1007\/s12350-019-01976-6_bib12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.nucmedbio.2005.06.003","article-title":"Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module","volume":"32","author":"Oh","year":"2005","journal-title":"Nucl Med Biol"},{"issue":"3","key":"10.1007\/s12350-019-01976-6_bib13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12350-017-1122-6","article-title":"Volume-based glucose metabolic analysis of FDG PET\/CT: The optimum threshold and conditions to suppress physiological myocardial uptake","volume":"26","author":"Manabe","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01976-6_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105682","article-title":"A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT","volume":"9","author":"Hirata","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1007\/s12350-019-01976-6_bib15","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"10.1007\/s12350-019-01976-6_bib16","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s12350-016-0525-0","article-title":"F-18 sodium fluoride PET\/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis","volume":"24","author":"Weinberg","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01976-6_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer (68)Ga-DOTANOC PET\/CT and (18)F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"issue":"11 Pt 1","key":"10.1007\/s12350-019-01976-6_bib18","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"Imaging Cardiac Sarcoidosis With FLT PET Compared With FDG Perfusion PET: A Prospective Pilot Study","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1007\/s12350-019-01976-6_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1293\/tox.22.93","article-title":"Imaging and targeting of the hypoxia-inducible factor 1-active microenvironment","volume":"22","author":"Kizaka-Kondoh","year":"2009","journal-title":"J Toxicol Pathol."},{"key":"10.1007\/s12350-019-01976-6_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213111","article-title":"Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer","volume":"14","author":"Kroenke","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1007\/s12350-019-01976-6_bib21","first-page":"462","article-title":"Selected molecular events in the pathogenesis of sarcoidosis - recent advances","volume":"83","author":"Kiszalkiewicz","year":"2015","journal-title":"Pneumonol Alergol Pol"},{"key":"10.1007\/s12350-019-01976-6_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00259-016-3541-z","article-title":"Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor","volume":"44","author":"Toyonaga","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01976-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-019-01976-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123015672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123015672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01976-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:23Z","timestamp":1761027083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123015672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1071358123015672"],"URL":"https:\/\/doi.org\/10.1007\/s12350-019-01976-6","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-019-01976-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}